Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Review

Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review

Jennifer M. Gierisch, Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, Amanda J. McBroom, Vic Hasselblad, Gillian D. Sanders and Evan R. Myers
Jennifer M. Gierisch
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remy R. Coeytaux
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Peragallo Urrutia
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura J. Havrilesky
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia G. Moorman
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. Lowery
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michaela Dinan
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda J. McBroom
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vic Hasselblad
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gillian D. Sanders
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan R. Myers
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; 2Duke Evidence-Based Practice Center, Duke Clinical Research Institute; Departments of 3Medicine, 4Community and Family Medicine, 5Obstetrics and Gynecology, and 6Biostatistics and Bioinformatics, Duke University School of Medicine; 7Duke Cancer Institute, Duke University Health System; 8Duke Clinical Research Institute, Durham; and 9Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-0298 Published November 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted a systematic review to estimate associations between oral contraceptive use and breast, cervical, colorectal, and endometrial cancer incidence. We searched PubMed, Embase, and Cochrane Database of Systematic Reviews. Study inclusion criteria were women taking oral contraceptives for contraception or ovarian cancer prevention; includes comparison group with no oral contraceptive use; study reports quantitative associations between oral contraceptive exposure and relevant cancers; controlled study or pooled patient-level meta-analyses; sample size for nonrandomized studies ≥100; peer-reviewed, English-language; published from January 1, 2000 forward. Random-effects meta-analyses were conducted by estimating pooled ORs with 95% confidence intervals (CIs). We included 44 breast, 12 cervical, 11 colorectal, and 9 endometrial cancers studies. Breast cancer incidence was slightly but significantly increased in users (OR, 1.08; CI, 1.00–1.17); results show a higher risk associated with more recent use of oral contraceptives. Risk of cervical cancer was increased with duration of oral contraceptive use in women with human papillomavirus infection; heterogeneity prevented meta-analysis. Colorectal cancer (OR, 0.86; CI, 0.79–0.95) and endometrial cancer incidences (OR, 0.57; CI, 0.43–0.77) were significantly reduced by oral contraceptive use. Compared with never use, ever use of oral contraceptives is significantly associated with decreases in colorectal and endometrial cancers and increases in breast cancers. Although elevated breast cancer risk was small, relatively high incidence of breast cancers means that oral contraceptives may contribute to a substantial number of cases. Cancer Epidemiol Biomarkers Prev; 22(11); 1931–43. ©2013 AACR.

Footnotes

  • Note: Supplementary data for this article are available at Cancer Epidemiology, Biomarkers & Prevention Online (http://cebp.aacrjournals.org/).

  • Received March 19, 2013.
  • Revision received August 21, 2013.
  • Accepted August 27, 2013.
  • ©2013 American Association for Cancer Research.
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (11)
November 2013
Volume 22, Issue 11
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review
Jennifer M. Gierisch, Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, Amanda J. McBroom, Vic Hasselblad, Gillian D. Sanders and Evan R. Myers
Cancer Epidemiol Biomarkers Prev November 1 2013 (22) (11) 1931-1943; DOI: 10.1158/1055-9965.EPI-13-0298

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review
Jennifer M. Gierisch, Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, Amanda J. McBroom, Vic Hasselblad, Gillian D. Sanders and Evan R. Myers
Cancer Epidemiol Biomarkers Prev November 1 2013 (22) (11) 1931-1943; DOI: 10.1158/1055-9965.EPI-13-0298
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Disclosure of Potential Conflicts of Interest
    • Disclaimer
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Epigenetic alterations and cervical cancer development
  • Area-Level Variation and HPV Vaccination
  • Lessons Learned from Setting Up a Prospective Study
Show more Review
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement